V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 200006515 | 200011794 | 1.75 | null | null | 2018-05-07 | 2019-09-25 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100958916 |
| 200006516 | 200011795 | 1.58 | 109.9 | null | 2020-07-11 | 2020-10-05 | DABRAFENIB | 02 | null | DABRAFENIB | 100483707 |
| 200006520 | 200011799 | 1.41 | 82.3 | Palliative (P) | null | 2018-10-31 | null | null | N | BINIMETINIB + ENCORAFENIB | 100263842 |
| 200006522 | 200011801 | null | null | null | null | 2016-10-27 | null | null | null | BLEOMYCIN | 101722528 |
| 200006523 | 200011802 | null | 70.5 | Palliative (P) | 2018-03-23 | 2018-03-23 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100891271 |
| 200006524 | 200011803 | 1.74 | 103.2 | null | 2019-07-24 | 2019-07-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100743672 |
| 200006525 | 200011804 | 1.77 | 77.7 | Palliative (P) | 2020-02-13 | 2020-02-27 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100717939 |
| 200006526 | 200011805 | 1.5 | 87.4 | Neo-adjuvant (N) | 2019-12-22 | 2019-12-24 | FEC | 02 | null | DABRAFENIB | 100355235 |
| 200006527 | 200011806 | null | null | null | null | 2016-03-14 | null | null | null | TRIAL | 100310108 |
| 200006529 | 200011808 | 1.63 | 84.55 | Palliative (P) | 2019-07-22 | 2019-08-03 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100061906 |
| 200006532 | 200011810 | 1.7 | 77 | Palliative (P) | 2017-11-27 | 2017-12-11 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100430484 |
| 200006533 | 200011811 | 1.76 | 99.5 | 03 | 2020-11-02 | 2020-11-16 | Ipilimumab | 02 | null | IPILIMUMAB | 101090334 |
| 200006534 | 200011812 | null | null | null | 2019-04-12 | 2019-04-12 | null | N | null | DABRAFENIB | 101539125 |
| 200006535 | 200011813 | 1.72 | 93 | Adjuvant (A) | 2016-07-24 | 2016-09-06 | Vemurafenib | 02 | N | IPILIMUMAB | 101860574 |
| 200006537 | 200011815 | 1.68 | 100 | Palliative (P) | 2016-12-02 | 2018-04-02 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 100835005 |
| 200006540 | 200011817 | null | 106.1 | Palliative (P) | 2016-08-30 | 2016-09-01 | Binimetinib + Encorafenib | 02 | N | IPILIMUMAB | 100262751 |
| 200006542 | 200011818 | 1.76 | 94.25 | null | 2019-01-13 | 2019-01-14 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101743195 |
| 200006543 | 200011819 | 1.85 | 78.1 | Palliative (P) | 2017-07-25 | 2017-08-20 | INTERIM Trial | N | null | IPILIMUMAB + NIVOLUMAB | 101852813 |
| 200006545 | 200011821 | 1.6 | 99.4 | Palliative (P) | null | 2018-01-11 | null | null | N | BINIMETINIB + ENCORAFENIB | 101514756 |
| 200006548 | 200011824 | 1.76 | 86 | Curative (C) | 2020-03-22 | 2021-07-17 | AZACITIDINE + VENETOCLAX | N | N | DABRAFENIB | 100328187 |
| 200006554 | 200011828 | null | null | null | 2018-01-15 | 2018-01-30 | null | 02 | null | TRIAL UNSPECIFIED | 100437880 |
| 200006556 | 200011830 | 1.63 | 114 | Palliative (P) | null | 2021-06-08 | null | null | N | LIPOSOMAL DOXORUBICIN | 101184349 |
| 200006557 | 200011831 | 1.71 | 106.6 | Adjuvant (A) | 2016-05-02 | 2016-05-15 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101465027 |
| 200006558 | 200011832 | null | 118.55 | 03 | 2017-10-05 | 2017-10-05 | DABRAFENIB | 02 | null | DABRAFENIB | 101491466 |
| 200006561 | 200011835 | 1.72 | 61.6 | 02 | 2018-05-17 | 2018-06-04 | DABRAFENIB | N | N | DABRAFENIB | 100471139 |
| 200006563 | 200011837 | 1.62 | 87.3 | Palliative (P) | 2018-10-22 | 2018-11-02 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101400001 |
| 200006564 | 200011838 | 1.9 | 57.7 | Palliative (P) | 2019-03-22 | 2019-04-19 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100832200 |
| 200006565 | 200011839 | 1.71 | 60.6 | Palliative (P) | null | 2022-05-19 | null | null | N | TALIMOGENE LAHERPAREPVEC | 101548457 |
| 200006566 | 200011840 | null | 51.9 | Palliative (P) | 2016-07-18 | 2016-07-20 | Rituximab | 02 | N | IPILIMUMAB | 100682293 |
| 200006567 | 200011841 | 1.68 | 95.3 | Palliative (P) | 2019-04-09 | 2019-04-23 | Ipilimumab | 02 | null | IPILIMUMAB | 101267686 |
| 200006568 | 200011842 | 1.6 | 71.35 | 03 | 2019-07-09 | 2019-08-22 | DABRAFENIB | 02 | null | DABRAFENIB | 100204134 |
| 200006570 | 200011844 | null | 89 | Palliative (P) | 2017-04-22 | 2017-05-13 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101678822 |
| 200006571 | 200011845 | 1.64 | 86.2 | null | 2020-03-25 | 2020-04-11 | Ipilimumab | 02 | null | IPILIMUMAB | 100277370 |
| 200006572 | 200011846 | 1.66 | 73 | Palliative (P) | 2019-04-24 | 2019-04-25 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101732836 |
| 200006576 | 200011850 | 1.9 | 89 | null | 2019-03-03 | 2019-04-09 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100820925 |
| 200006577 | 200011851 | null | 89 | Palliative (P) | 2017-05-14 | 2017-06-07 | PERM Trial | 02 | N | IPILIMUMAB + NIVOLUMAB | 101733885 |
| 200006578 | 200011852 | null | null | null | null | 2019-08-15 | null | null | null | PCV | 100467632 |
| 200006582 | 200011856 | null | 69 | 03 | 2018-09-05 | 2018-09-05 | Cisplatin + Dacarbazine | 02 | N | DABRAFENIB | 101258734 |
| 200006583 | 200011857 | 0 | 0 | Palliative (P) | 2019-09-29 | 2019-10-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101313552 |
| 200006584 | 200011858 | null | null | null | null | 2021-11-17 | null | null | null | VEMURAFENIB | 101155376 |
| 200006585 | 200011859 | 1.83 | 79.5 | Palliative (P) | 2016-06-24 | 2016-07-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100221601 |
| 200006587 | 200011861 | 1.66 | 71.4 | 03 | 2019-07-12 | 2019-08-30 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 100894045 |
| 200006588 | 200011862 | 1.62 | 86 | Palliative (P) | 2017-05-29 | 2017-06-07 | null | 02 | null | DABRAFENIB | 101521887 |
| 200006590 | 200011864 | null | 82.3 | 03 | 2019-04-03 | 2019-04-03 | Trial Unspecified | 02 | null | IPILIMUMAB | 101449414 |
| 200006592 | 200011866 | null | 62 | Palliative (P) | 2019-09-11 | 2019-10-03 | Ipilimumab | 02 | N | IPILIMUMAB | 101139242 |
| 200006596 | 200011870 | 1.62 | 77.6 | Palliative (P) | 2017-10-01 | 2017-11-27 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101751698 |
| 200006597 | 200011871 | null | 61 | Adjuvant (A) | null | 2017-05-10 | Trial Unspecified | 2 | null | DABRAFENIB | 100557113 |
| 200006599 | 200011873 | 1.62 | 77.95 | Palliative (P) | 2017-12-01 | 2019-01-06 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101167498 |
| 200006601 | 200011875 | 1.62 | 77.1 | Palliative (P) | 2020-11-18 | 2020-12-06 | IPILIMUMAB + NIVOLUMAB | 02 | null | IPILIMUMAB + NIVOLUMAB | 101198485 |
| 200006602 | 200011876 | 1.62 | 76 | Palliative (P) | 2016-07-04 | 2016-07-04 | IPILIMUMAB + NIVOLUMAB | 02 | N | IPILIMUMAB + NIVOLUMAB | 101279906 |